BHST (BioHarvest Sciences) Total Assets: $45.56 Mil (As of Mar. 2026)


BHST BioHarvest Sciences Inc BHST
63 GF Score
Price $2.79
GF Value $8.57
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BioHarvest Sciences Total Assets?

BioHarvest Sciences BHST +0.72% 63 Total Assets is $45.56 Mil as of Mar. 2026. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.57 (Possible Value Trap). The stock has 4 warning signs investors should review.

BioHarvest Sciences's Total Assets for the quarter that ended in Mar. 2026 was $45.56 Mil.

During the past 12 months, BioHarvest Sciences's average Total Assets Growth Rate was 9.50% per year. During the past 3 years, the average Total Assets Growth Rate was 47.60% per year. During the past 5 years, the average Total Assets Growth Rate was 48.70% per year. During the past 10 years, the average Total Assets Growth Rate was 99.50% per year.

During the past 12 years, BioHarvest Sciences's highest 3-Year average Total Assets Growth Rate was 315.50%. The lowest was 14.60%. And the median was 54.80%.

Total Assets is connected with ROA %. BioHarvest Sciences's annualized ROA % for the quarter that ended in Mar. 2026 was -22.66%. Total Assets is also linked to Revenue through Asset Turnover. BioHarvest Sciences's Asset Turnover for the quarter that ended in Mar. 2026 was 0.18.

BioHarvest Sciences  (NAS:BHST) Total Assets Explanation

Total Assets is connected with ROA %.

BioHarvest Sciences's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-10.564/( (47.665+45.558)/ 2 )
=-10.564/46.6115
=-22.66 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

BioHarvest Sciences's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=8.507/( (47.665+45.558)/ 2 )
=8.507/46.6115
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

BioHarvest Sciences Total Assets Related Terms

BioHarvest Sciences Total Assets Historical Data

* Premium members only.

The historical data trend for BioHarvest Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences Total Assets Chart

BioHarvest Sciences Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.21 9.39 15.00 25.00 47.67

BioHarvest Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.59 27.80 35.19 47.67 45.56
BHST
63GF Score
BioHarvest Sciences Inc BHST
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioHarvest Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

BioHarvest Sciences's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=25.448+22.217
=47.67

BioHarvest Sciences's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=23.023+22.535
=45.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $45.56 Mil mean?
BioHarvest Sciences (BHST) has a Total Assets of $45.56 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on BioHarvest Sciences and its competitors.
Is BioHarvest Sciences' Total Assets too high?
BioHarvest Sciences' current Total Assets is $45.56 Mil. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' Total Assets compare to BRID and BOF?
BioHarvest Sciences' Total Assets of $45.56 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Consumer Packaged Goods company?
A good Total Assets depends on the Consumer Packaged Goods industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on BioHarvest Sciences and its competitors. BioHarvest Sciences's current Total Assets is $45.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.57, compared to a current price of $2.79 — trading 67.4% below its estimated fair value. The current Total Assets is $45.56 Mil. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current Total Assets is $45.56 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioHarvest Sciences (BHST) Overvalued in 2026?

Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued. The current stock price of $2.79 is trading 67.4% below its estimated GF Value™ of $8.57. GuruFocus considers BioHarvest Sciences to be Possible Value Trap.

Key valuation signals for BHST:

  • Total Assets: $45.56 Mil
  • GF Value™: $8.57 vs. price of $2.79 (67.4% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioHarvest Sciences Business Description

Other Exchanges 8MV0:Germany
Address 1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score

Get the complete analysis for BHST

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.79
Price
$8.57
GF Value